GMED rides on NuVasive synergies, strong cash flow and rapid innovation, but macro pressures and rising costs cloud its near-term outlook.
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for April 8th

06:51am, Wednesday, 08'th Apr 2026
BE, SM, KRUS, GMED and BP have been added to the Zacks Rank #1 (Strong Buy) List on April 8th, 2026.
Flowserve, California Resources and Globus Medical stand out as sales-growth buys as oil spikes and Iran-Strait tensions shake markets.
Allspring Global Investments Holdings LLC trimmed its stake in shares of Globus Medical, Inc. (NYSE: GMED) by 6.2% in the fourth quarter, according to the company in its most recent filing with the Se
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Globus Medical Announces Board Departure

05:25pm, Monday, 23'rd Mar 2026
AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical I
GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.
Bridgefront Capital LLC acquired a new stake in Globus Medical, Inc. (NYSE: GMED) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
ArrowMark Colorado Holdings LLC increased its holdings in Globus Medical, Inc. (NYSE: GMED) by 25.1% during the third quarter, according to the company in its most recent 13F filing with the Securitie
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Globus Medical (GMED) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
Elo Mutual Pension Insurance Co grew its stake in shares of Globus Medical, Inc. (NYSE: GMED) by 106.2% in the third quarter, according to the company in its most recent filing with the SEC. The firm
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GMED gains share in musculoskeletal solutions with spine growth, rapid product launches and strong cash, but macro headwinds and rising costs remain risks.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE